(E)-3-(2,4-dimethoxypyrimidin-5-yl)-N-[1-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]pyrazol-4-yl]prop-2-enamide
C18H20N6O4 — CID 74225105
Data last refreshed: (MolForge compound catalog, from PubChem)
About (E)-3-(2,4-dimethoxypyrimidin-5-yl)-N-[1-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]pyrazol-4-yl]prop-2-enamide
(E)-3-(2,4-dimethoxypyrimidin-5-yl)-N-[1-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]pyrazol-4-yl]prop-2-enamide (PubChem CID 74225105) has the molecular formula C18H20N6O4 and a molecular weight of 384.40 g/mol. Its IUPAC name is (E)-3-(2,4-dimethoxypyrimidin-5-yl)-N-[1-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]pyrazol-4-yl]prop-2-enamide.
Molecular Properties
| Compound Name | (E)-3-(2,4-dimethoxypyrimidin-5-yl)-N-[1-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]pyrazol-4-yl]prop-2-enamide |
|---|---|
| PubChem CID | 74225105 |
| Molecular Formula | C18H20N6O4 |
| Molecular Weight | 384.40 g/mol |
| Exact Mass | 384.15 |
| IUPAC Name | (E)-3-(2,4-dimethoxypyrimidin-5-yl)-N-[1-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]pyrazol-4-yl]prop-2-enamide |
| SMILES | COc1ncc(/C=C/C(=O)Nc2cnn(Cc3c(C)noc3C)c2)c(OC)n1 |
| InChI | InChI=1S/C18H20N6O4/c1-11-15(12(2)28-23-11)10-24-9-14(8-20-24)21-16(25)6-5-13-7-19-18(27-4)22-17(13)26-3/h5-9H,10H2,1-4H3,(H,21,25)/b6-5+ |
| InChIKey | BITNIKQECKMJPS-AATRIKPKSA-N |
| XLogP | 2.00 |
| TPSA | 117.19 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 384.40 |
| LogP ≤ 5 | 2.00 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 74225105 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.